Ying Xiang

4.6k total citations · 1 hit paper
71 papers, 3.2k citations indexed

About

Ying Xiang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Ying Xiang has authored 71 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Cancer Research and 17 papers in Immunology. Recurrent topics in Ying Xiang's work include Virus-based gene therapy research (13 papers), MicroRNA in disease regulation (12 papers) and Herpesvirus Infections and Treatments (9 papers). Ying Xiang is often cited by papers focused on Virus-based gene therapy research (13 papers), MicroRNA in disease regulation (12 papers) and Herpesvirus Infections and Treatments (9 papers). Ying Xiang collaborates with scholars based in China, United States and Singapore. Ying Xiang's co-authors include Robert H. Silverman, Xinjing Wang, Xiaoli Wu, Qinyi Zhu, Xipeng Wang, Xin Chen, Bingbing Jia, Jinfu Wang, Guoping Huang and Richard Condit and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Blood.

In The Last Decade

Ying Xiang

68 papers receiving 3.1k citations

Hit Papers

Dendritic cell biology and its role in tumor immunotherapy 2020 2026 2022 2024 2020 100 200 300

Peers

Ying Xiang
Michael C. Schmid United Kingdom
Scott Lonning United States
Galen H. Fisher United States
Scott A. Ness United States
Martin Oft United States
Ferenc A. Scheeren Netherlands
Ying Xiang
Citations per year, relative to Ying Xiang Ying Xiang (= 1×) peers Hisashi Iizasa

Countries citing papers authored by Ying Xiang

Since Specialization
Citations

This map shows the geographic impact of Ying Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Xiang more than expected).

Fields of papers citing papers by Ying Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Xiang. The network helps show where Ying Xiang may publish in the future.

Co-authorship network of co-authors of Ying Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Xiang. A scholar is included among the top collaborators of Ying Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Xiang. Ying Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Yuqing, et al.. (2025). Prospects and challenges of ovarian cancer organoids in chemotherapy research (Review). Oncology Letters. 29(4). 1–13.
2.
Xiao, Haibing, Yuchen Liu, Dinglin Liu, Ying Xiang, & Weijia Zhang. (2025). Exploring Triptolide's Dual Role in Inflammation and Oxidative Stress: Responses of Organelles. Journal of Biochemical and Molecular Toxicology. 39(7). e70371–e70371.
3.
Wang, Qian, et al.. (2024). PLK3 is linked with higher tumor stage and unfavorable prognosis in patients with colorectal cancer. Biomarkers in Medicine. 18(6). 221–230. 1 indexed citations
4.
5.
Zhang, Ying, Lisi Zeng, Juan Wang, et al.. (2021). Multifunctional Non-Coding RNAs Mediate Latent Infection and Recurrence of Herpes Simplex Viruses. Infection and Drug Resistance. Volume 14. 5335–5349. 5 indexed citations
6.
Cai, Wen-Qi, Lisi Zeng, Lifeng Wang, et al.. (2020). The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells. Frontiers in Oncology. 10. 1249–1249. 127 indexed citations
7.
Liu, Xiaoqin, Hong-Yi Xin, Zhaowu Ma, et al.. (2018). Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins. Drug Delivery. 25(1). 1950–1962. 23 indexed citations
9.
Wang, Dong, Xianwang Wang, Xiaochun Peng, et al.. (2018). CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research. Cancer Gene Therapy. 25(5-6). 93–105. 41 indexed citations
10.
Wu, Quanfeng, Xiaoli Wu, Ying Xiang, et al.. (2017). Suppression of endothelial cell migration by tumor associated macrophage-derived exosomes is reversed by epithelial ovarian cancer exosomal lncRNA. Cancer Cell International. 17(1). 62–62. 80 indexed citations
11.
Chen, Xin, Ying Xiang, Xinjing Wang, et al.. (2017). Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization. Oncology Reports. 38(1). 522–528. 217 indexed citations
12.
Xiang, Ying, Qiying Li, Jianghong Wang, et al.. (2013). The construction and expression of Luffin-β-targeted fusion immunotoxin as well as its inhibitory effect on non-small cell lung cancer cells. Tumori. 33(4). 314–320. 2 indexed citations
13.
Qiao, Yu, Ning Ma, Xidi Wang, et al.. (2011). MiR-483-5p controls angiogenesis in vitro and targets serum response factor. FEBS Letters. 585(19). 3095–3100. 63 indexed citations
14.
Ma, Ning, Fuyuan Li, Dan Li, et al.. (2011). Igf2-derived intronic miR-483 promotes mouse hepatocellular carcinoma cell proliferation. Molecular and Cellular Biochemistry. 361(1-2). 337–343. 20 indexed citations
15.
Ma, Ning, Ying Xiang, Yanfen Zhang, & Xu Gao. (2011). A microRNA “target pools” remains mysterious. Journal of Cellular Biochemistry. 113(1). 1–2. 3 indexed citations
16.
Xie, Chungang, Jinfu Wang, Ying Xiang, et al.. (2006). Cocultivation of umbilical cord blood CD34+cells with retro-transduced hMSCs leads to effective amplification of long-term culture-initiating cells. World Journal of Gastroenterology. 12(3). 393–393. 12 indexed citations
17.
Xie, Chungang, Bingbing Jia, Ying Xiang, et al.. (2006). Support of hMSCs transduced with TPO/FL genes to expansion of umbilical cord CD34+ cells in indirect co-culture. Cell and Tissue Research. 326(1). 101–110. 8 indexed citations
18.
Zhou, Yan, et al.. (2003). Proteasome-Mediated Degradation of RNase L in Response to Phorbol-12-Myristate-13-Acetate (PMA) Treatment of Mouse L929 Cells. Journal of Interferon & Cytokine Research. 23(10). 565–573. 9 indexed citations
19.
Casey, Graham, Phillippa J. Neville, Sarah J. Plummer, et al.. (2002). RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nature Genetics. 32(4). 581–583. 226 indexed citations
20.
Xiang, Ying, Donald R. Latner, Edward G. Niles, & Richard Condit. (2000). Transcription Elongation Activity of the Vaccinia Virus J3 Protein in Vivo Is Independent of Poly(A) Polymerase Stimulation. Virology. 269(2). 356–369. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026